PIK3CA mutations and first-line outcomes in endocrine-resistant HR+/HER2- metastatic breast cancer: A multicentric real-world study.
Year: 2025
Type: article
Language: en
Topic: PI3K/AKT/mTOR signaling in cancer
Authors and affiliations:
raw_author_name: Maria Vittoria Dieci
raw_affiliation_strings: Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy. Electronic address: mariavittoria.dieci@unipd.it
raw_author_name: Grazia Vernaci
raw_affiliation_strings: Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy
raw_author_name: Chiara Colangelo
raw_affiliation_strings: Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy; Basic and Translational Oncology, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy; Functional Proteomic Section, Department of Life Sciences, University of Siena, Siena 53100, Italy
raw_author_name: Emilio Bria
raw_affiliation_strings: University Cattolica del Sacro Cuore, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy; Ospedale Isola Tiberina - Gemelli Isola, Rome, Italy
raw_author_name: Davide Massa
raw_affiliation_strings: Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy
raw_author_name: Elisabetta Di Liso
raw_affiliation_strings: Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy
raw_author_name: Carlo Alberto Giorgi
raw_affiliation_strings: Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy
raw_author_name: Tommaso Giarratano
raw_affiliation_strings: Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy
raw_author_name: Davide Napetti
raw_affiliation_strings: Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy
raw_author_name: Giorgio Bonomi
raw_affiliation_strings: Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy
raw_author_name: Francesca Zanghì
raw_affiliation_strings: Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy
raw_author_name: Michele Bottosso
raw_affiliation_strings: Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy
raw_author_name: Elisabetta Lazzarini
raw_affiliation_strings: Basic and Translational Oncology, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy
raw_author_name: Laura Santarelli
raw_affiliation_strings: Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy; Basic and Translational Oncology, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy
raw_author_name: Andrea Boscolo Bragadin
raw_affiliation_strings: Basic and Translational Oncology, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy
raw_author_name: Stefano Indraccolo
raw_affiliation_strings: Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Basic and Translational Oncology, Veneto Institute of Oncology IOV - IRCCS, Padua, Italy
raw_author_name: Valentina Guarneri
raw_affiliation_strings: Department of Surgery, Oncology and Gastroenterology, University of Padova, Padova, Italy; Division of Oncology 2, Istituto Oncologico Veneto IRCCS, Padova, Italy